Transcatheter Valve-in-Valve Implantation for Failing Bioprosthetic Triscupid Valves

Transcatheter aortic valve‐in‐valve implantation in failed stentless bioprostheses

“…For almost a decade, transcatheter valve‐in‐valve implantation (ViV‐TAVI) has been an important off‐label application for the rapidly growing field of transcathether aortic valve implantation (TAVI) . In 2015, following several observational data analyses—ViV‐TAVI gained definitive recognition as a feasible and beneficial procedure in patients with failed surgically implanted bioprosthetic valves and was approved by the Food and Drug Administration as an extended indication for the two most popular, self‐ and balloon‐expandable, systems . Rapid worldwide growth in the number of TAVI procedures is accompanied by the natural transition to lower risk populations and, collaterally, patients with severe aortic stenosis treated surgically are becoming younger.…”

Transcatheter “valve-in-valve” implantation of bioprosthesis in failed surgical tricuspid bioprosthesis (first experience in Russia)

“…Метод "клапан-в-клапан" представляется оптимальным для лечения структурной дегенерации биопротеза ТК у больных высокого риска. Опыт данных операций в мировой практике невелик [12]. С 2008г существует международный многоцентровой регистр TVIV, в который к 2015г были включены 156 пациентов с дисфункцией протезированного ТК.…”